System Transmission

Top Signal

100#1 JOB

Activity

2188Ripe

+949 today

System

Live1m

Terminal Asset View

stockNASDAQ

ENTA

$12.70-5.29%

Enanta Pharmaceuticals Inc

Too-Late

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

2Too-Late

Live Analysis Active

Company Mission

Enanta Pharmaceuticals creates antiviral medicines that fight specific viruses in the human body. Doctors prescribe these drugs to patients with viral infections like hepatitis and respiratory viruses. The company makes money by selling these medicines and through partnerships where larger pharmaceutical companies help develop and market their drugs.

ENT

Industry Context

The pharmaceutical industry focuses on developing treatments for diseases. Companies in this space often see increased attention when they have promising drugs in development or when health concerns like viral outbreaks create demand for new treatments.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

68Matrix

Market Momentum

38.9— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

2.4x— Normal Volume

Today's Change

-5.29%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ENTA across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 04:08 AM UTC

As-of 03-15-2026 03:53 UTC

Discovers and develops new medicines for infectious diseases, earning money by licensing these drugs to larger pharmaceutical companies.

Volume spiked 2 times above normal recently, suggesting increased institutional interest as the stock tests lower price levels showing showing.

Watch for potential breakout moves as the stock shows technical squeeze patterns while trading below key moving averages, suggesting moving averages.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...